A new treatment and updated clinical practice guidelines for MASLD

Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335–1347 (2023).

Article  PubMed  Google Scholar 

Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542–1556 (2023).

Article  CAS  PubMed  Google Scholar 

Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537–2564 (2021).

Article  CAS  PubMed  Google Scholar 

Sanyal, A. J. et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N. Engl. J. Med. 385, 1559–1569 (2021).

Article  CAS  PubMed  Google Scholar 

Burra, P., Becchetti, C. & Germani, G. NAFLD and liver transplantation: disease burden, current management and future challenges. JHEP Rep. 2, 100192 (2020).

Article  PubMed  Google Scholar 

FDA approves first treatment for patients with liver scarring due to fatty liver disease. FDA https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease (2024).

Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497–509 (2024).

Article  PubMed  Google Scholar 

Gawrieh, S. et al. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD. J. Hepatol. 81, 600–608 (2024).

Article  PubMed  Google Scholar 

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO). Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81, 492–542 (2024).

Allen, A. M., Younossi, Z. M., Diehl, A. M., Charlton, M. R. & Lazarus, J. V. Envisioning how to advance the MASH field. Nat. Rev. Gastroenterol. Hepatol. 21, 726–738 (2024).

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif